Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Wave Life Sciences
WVE
$1.02B
| $3.73M | ﹤0.01% |
573,187
+311,973
| +119% | +$2.06M |
|
|
HUT
2327
Hut 8
HUT
$10.2B
| $3.72M | ﹤0.01% |
200,003
+100,948
| +102% | +$1.51M |
|
|
PONY
2328
Pony AI Inc
PONY
$3.62B
| $3.71M | ﹤0.01% |
+281,210
| New | +$3.4M |
|
|
PPLI
2329
People Inc
PPLI
$3.01B
| $3.71M | ﹤0.01% |
99,273
-59,219
| -37% | -$2.14M |
|
2330
UFP Technologies
UFPT
$2.48B
| $3.7M | ﹤0.01% |
15,174
+5,365
| +55% | +$1.21M |
|
2331
AGNC Investment
AGNC
$13B
| $3.7M | ﹤0.01% |
402,555
-396,585
| -50% | -$3.55M |
|
2332
CALL
Joby Aviation
JOBY
$8.17B
| $3.69M | ﹤0.01% |
+350,000
| New | +$2.53M |
|
2333
Aurora
AUR
$13.4B
| $3.69M | ﹤0.01% |
703,954
-791,771
| -53% | -$4.97M |
|
2334
Build-A-Bear
BBW
$474M
| $3.69M | ﹤0.01% |
71,519
+10,416
| +17% | +$441K |
|
2335
Edgewise Therapeutics
EWTX
$4.69B
| $3.69M | ﹤0.01% |
281,250
+172,688
| +159% | +$2.49M |
|
2336
Perimeter Solutions
PRM
$5.53B
| $3.69M | ﹤0.01% |
264,869
+100,028
| +61% | +$1.15M |
|
2337
Valvoline
VVV
$4.31B
| $3.67M | ﹤0.01% |
96,970
-47,674
| -33% | -$1.67M |
|
|
ALEX
2338
DELISTED
Alexander & Baldwin
ALEX
| $3.67M | ﹤0.01% |
205,812
+44,179
| +27% | +$769K |
|
2339
Lakeland Financial Corp
LKFN
$1.56B
| $3.67M | ﹤0.01% |
59,705
+22,029
| +58% | +$1.28M |
|
2340
CareDx
CDNA
$2.45B
| $3.65M | ﹤0.01% |
186,985
+90,985
| +95% | +$1.62M |
|
|
CDTX
2341
CALL
DELISTED
Cidara Therapeutics
CDTX
| $3.65M | ﹤0.01% |
+75,000
| New | +$1.8M |
|
|
CDTX
2342
PUT
DELISTED
Cidara Therapeutics
CDTX
| $3.65M | ﹤0.01% |
+75,000
| New | +$1.8M |
|
2343
Vishay Intertechnology
VSH
$5.11B
| $3.65M | ﹤0.01% |
229,655
+40,107
| +21% | +$558K |
|
|
ITWO
2344
ProShares Russell 2000 High Income ETF
ITWO
$202M
| $3.64M | ﹤0.01% |
100,000
| – | – |
|
2345
Grindr
GRND
$2.74B
| $3.64M | ﹤0.01% |
160,424
+1,003
| +0.6% | +$22K |
|
2346
1st Source
SRCE
$2.13B
| $3.64M | ﹤0.01% |
58,667
+20,747
| +55% | +$1.23M |
|
2347
Northwest Bancshares
NWBI
$2.31B
| $3.63M | ﹤0.01% |
284,257
+87,092
| +44% | +$1.06M |
|
|
ARI
2348
Apollo Commercial Real Estate
ARI
$886M
| $3.62M | ﹤0.01% |
374,299
+53,269
| +17% | +$502K |
|
2349
CALL
Zscaler
ZS
$30.4B
| $3.61M | ﹤0.01% |
11,500
-88,500
| -89% | -$22.1M |
|
2350
Algonquin Power & Utilities
AQN
$4.48B
| $3.61M | ﹤0.01% |
629,957
+35,889
| +6% | +$197K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.